The Pershing Square Foundation supports exceptional leaders and innovative organizations that tackle important social issues and deliver scalable and sustainable impact. With a focus on health and medicine, education, economic development, and social justice, the foundation aims to bring about breakthroughs around the world by investing in pioneering individuals and mission-driven entities.
The MIND Prize, funded by The Pershing Square Foundation, focuses on revolutionizing our understanding and management of neurodegenerative diseases (NDDs) through cutting-edge research. This initiative supports early-to-mid-career investigators in exploring innovative approaches to predict, prevent, and treat conditions such as Alzheimer’s Disease and Dementia. The program encourages interdisciplinary collaborations and the development of novel technologies, techniques, and therapeutic strategies. Winners receive $250,000 per year for three years and become part of a unique research network, with additional benefits including facilitated partnerships, networking opportunities with industry mentors and investors, special events, and an annual retreat.